When was Schrodinger founded?

Schrodinger was founded in 1990 and raised its 1st funding round 17 years after it was founded.

Where is Schrodinger located?

Schrodinger is headquartered in New York City, United States. It is registered at Portland, Oregon.

How many employees does Schrodinger have?

As of Jun 30, 2026, the latest employee count at Schrodinger is 1002.

Is Schrodinger a funded company?

Schrodinger is a funded company, having raised a total of $162M across 9 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jan 01, 2007.

How much is Schrodinger worth?

The last known valuation of Schrodinger was $***** as of Jan 27, 2020.

When was the latest funding round of Schrodinger?

Schrodinger's latest funding was a $***** Grant (prize money) round on Nov 18, 2021, with participation from 1 investor.

What is the annual revenue of Schrodinger?

Annual revenue of Schrodinger is between $100M and $500M as on Dec 31, 2025

Where does Schrodinger rank among its competitors?

Schrodinger ranks 1st amongst 254 active competitors, of which 90 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Isomorphic Labs, which secured $2.1B in May, 2026.

Who are the top competitors of Schrodinger?

Schrodinger's top competitors include Recursion Pharmaceuticals, XtalPi and PhaseCraft. Among them, Isomorphic Labs secured the most recent funding round in May, 2026.

Schrodinger - 2026 Company Profile, Team, Funding, Competitors & Financials

Schrodinger is an acquired company based in New York City (United States), founded in 1990 by William A Goddard and Richard A Friesner. It operates as a Provider of a web-based simulation and modelling tool. Schrodinger has raised $162M in funding from Gates and WuXi AppTec, with last known valuation of $*****. The company has 254 active competitors, including 90 funded and 19 that have exited. Its top competitors include companies like Recursion Pharmaceuticals, XtalPi and PhaseCraft.

Company Details

Provider of a web-based simulation and modelling tool for computational chemistry and drug discovery. It has developed a software solution for computational chemistry and material designing. Its proprietary platform is a simulation-based modelling platform that offers protein-protein docking, protein modelling, protein engineering, and antibody modelling study. It also offers products that help in treating oesophageal, ovarian, pancreatic, breast, and lung cancers.

Website: www.schrodinger.com/
Social
Email ID: *****@schrodinger.com
Phone Number: +1 **********
Registered Address: Portland, Oregon

Key Metrics

Founded Year

1990

Location

New York City, United States

Stage

Acquired

Total Funding

$162M in 9 rounds

Latest Funding Round

Grant (prize money), Nov 18, 2021, $*****

Last Known Valuation

$***** as on Jan 27, 2020

Investors

Gates & 17 more

Ranked

1^st among 254 active competitors

Annual Revenue

$100M - $500M as on Dec 31, 2025

Employee Count

1,002 as on Jun 30, 2026

Investment & Acquisitions

Ajax & 5 more

Similar Companies

Recursion Pharmaceuticals & 279 more

Exit Details

Acquired by Baron Funds (May 18, 2020)

View Schrodinger's full profile

Schrodinger is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
DINGER GmbH CIN: B1601_HRB220765 , Germany, Active		-	-
SCHRODINGER, INC. CIN: 954284541 , United States, Active	Dec 26, 999	$100M - $500M (As on Dec 31, 2025)	652 (As on Dec 31, 2024)	-

Schrodinger got acquired by Baron Funds on May 18, 2020.

Click here to take a look at Schrodinger's acquisition in detail

Schrodinger has raised a total funding of $162M over 9 rounds. Its first funding round was on Jan 01, 2007. Its latest funding round was a Grant (prize money) round on Nov 18, 2021 for $*****. 1 investor participated in its latest round. Schrodinger has 16 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of Schrodinger:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 18, 2021	9652403	Grant (prize money)	2513266	2353429	2615382	6765670
May 21, 2019	1919748	Series D	8216696	8628848	9482027	Deerfield & 6 more
Jun 19, 2015	4516628	Series C	9482488	9602026	5259960	4037956

Access funding benchmarks and valuations. Sign up today!

View details of Schrodinger's funding rounds and investors

The founders of Schrodinger are William A Goddard and Richard A Friesner.

Here are the details of Schrodinger's key team members:

William A Goddard: Co-Founder of Schrodinger.
Contact Info: 1 email address
Richard A Friesner: Co-Founder of Schrodinger.
Contact Info: 1 email address

View details of Schrodinger's Founder profiles and Board Members

Schrodinger's employee count trend

Schrodinger has 1,002 employees as of Jun 26. Here is Schrodinger's employee count trend over the years:

Uncover Schrodinger's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Schrodinger include Recursion Pharmaceuticals, XtalPi and PhaseCraft. Here is the list of Top 10 competitors of Schrodinger, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Schrodinger 1990, New York City (United States), Acquired	Provider of a web-based simulation and modelling tool	$162M	HTIF, Deerfield & 16 others	74/100
2nd	Recursion Pharmaceuticals 2013, New York (United States), Public	AI-enabled drug discovery and development platform for novel therapeutics	$452M	Baillie Gifford, Felicis Ventures & 47 others	72/100
3rd	XtalPi 2014, Cambridge (United States), Public	AI-based drug research and development company	$785M	Orbimed, SoftBank Vision Fund & 25 others	67/100
4th	PhaseCraft 2019, Bristol (United Kingdom), Series B	Provider of quantum simulation systems	$56.4M	LocalGlobe, UCL Technology Fund & 11 others	64/100
5th	Isomorphic Labs 2021, London (United Kingdom), Series B	Digital platform focused on revolutionizing drug discovery using AI	$2.7B	Thrive Capital, CapitalG & 6 others	64/100
6th	Causaly 2018, London (United Kingdom), Series B	Provider of an AI platform for life sciences and biomedical research	$93M	Iconiq Capital, Index Ventures & 14 others	63/100
7th	Xaira 2023, San Francisco (United States), Series D	AI-enabled platform for drug discovery and development	$1B	Arch Venture Partners, Foresite Labs & 11 others	63/100
8th	Valo Health 2019, Boston (United States), Series B	AI-powered platform for drug discovery and development	$450M	PSP Investments, Koch Disruptive Technologies ... & 7 others	63/100
9th	Tandem AI 2021, New York (United States), Series A	AI-based drug discovery tool for researchers	$82M	Orbimed, Chengwei Capital & 4 others	62/100
10th	In Silico 2014, Cambridge (United States), Public	AI-enabled bioinformatics platform for drug discovery and biomarker development	$510M	Qiming Venture Partners, Prosperity7 Ventures ... & 36 others	62/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Schrodinger's competitors? Click here to see the top ones

Schrodinger has not made any acquisitions yet. Schrodinger has made 6 investments.

Here is the list of latest three $investments:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
May 13, 2024	Investments	Ajax	2019	Cambridge (United States)
Jun 01, 2021	Investments	Ajax	2019	Cambridge (United States)
Sep 17, 2018	Investments	Morphic Therapeutic	2015	Waltham (United States)